The inhibition of miR-503-3p upregulates DACT2 and inhibits Wnt/ β-catenin pathway in BC cells, resulting in glycolysis suppression and mitochondrial oxidative phosphorylation increase [60]. The gene discussed is DACT2; the disease is breast cancer.